IndraLab

Statements


USP13 activates MCL1. 16 / 16
| 16

reach
"Taken together, our results indicated that pharmacological inhibition of USP13 by spautin-1 reduced MCL1 protein abundance and increased tumor cell sensitivity to ABT-263."

reach
"The deubiquitinase (DUB) USP13 promotes Mcl-1 stabilisation in cervical cancer."

reach
"We subsequently investigated the impact of USP13 mediated MCL1 stabilization on tumor malignancy."

reach
"Conversely, overexpression of WT USP13, but not the USP13 mutant, enhanced the half-life of Mcl-1 to ~ 300min."

reach
"Our data shows that USP13 and Mcl-1 protein expression correlates, suggesting that USP13 mediated Mcl-1 stabilisation is clinically relevant."

reach
"As a complimentary approach, we lentivirally expressed ectopic USP13 into OVCAR5, PC9 and NCI-H2170 cells, whose endogenous USP13 levels were relatively low, and found that overexpression of USP13 increased MCL1 protein, but not mRNA, abundance."

reach
"These data demonstrate that USP13 promotes the stability of Mcl-1 in HPV+ cervical cancer cells by protecting it from proteasomal degradation."

reach
"First, USP13 promoted MCL1 protein stability in multiple lung and ovarian cancer cell models."

reach
"In lung infection, USP13 are aberrantly expressed, inhibition of USP13 reduces the abundance of anti-apoptotic protein MCL1 in the lung [42]."

reach
"USP13 promotes MCL1 protein stability."

reach
"USP13 promotes Mcl-1 stability."

reach
"Finally, USP13 inhibition reduced MCL1 protein abundance and thereby increased tumor cell sensitivity to BH3 mimetic inhibitor ABT-263."

reach
"Conversely, exogenous USP13 overexpression evidently prolonged the half-life of endogenous MCL1 in NCI-H2170 and PC9 cells."

reach
"We concluded that USP13 promoted MCL1 stability at the post transcriptional level in lung and ovarian cancer cells."

reach
"USP13 knockdown by siRNA markedly reduced the half-life of MCL1 in TOV-21G and SW-1573 cells."

reach
"We further report that genetic or pharmacological inhibition of USP13 considerably reduces MCL1 protein abundance and significantly increases tumor cell sensitivity to BH3 mimetic inhibitors targeting BCL-2 and BCL-XL."